CD8A and cancer: DeNardo et al. [33] also suggest that even though CD8+ CTLs can destroy tumor cells in acute inflammation environment at the early initiation and growth stages, its anti-tumor effect is suppressed in the followed chronic inflammation stage if cancer cells are not completely eliminated.